Sun Pharma profit zooms 4-fold for the 3rd quater
New Delhi: Drug major Sun Pharmaceutical Industries (Sun Pharma) on Tuesday reported nearly four-fold jump in its consolidated net profit at Rs 1,241.85 crore for the third quarter ended on December 31, 2018.
Net Profit Q3
The company (Sun Pharma) had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal hit by one-time deferred tax adjustment. The net profit for Q3 FY19 resulted a net profit margin of 16.2 per cent.
Sun Pharma MD Dilip Shanghvi said: “Our focus on execution is reflected in the Q3 performance.” He further added that the company remains committed towards executing its global specialty strategy, strengthening core operations and enhancing its overall efficiencies.